Cargando…
Impact of a Novel Insulin Management Service on Non-insulin Pharmaceutical Expenses
BACKGROUND: Studies have shown that improvements in glycemic control are associated with avoidance or delayed onset of diabetes complications, improvements in health-related quality of life, and reductions in diabetes-related health care costs. Clinical practice guidelines recommend maintaining a he...
Autores principales: | Schneider, John E., Parikh, Anjani, Stojanovic, Ivana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Columbia Data Analytics, LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309958/ https://www.ncbi.nlm.nih.gov/pubmed/32685571 http://dx.doi.org/10.36469/9783 |
Ejemplares similares
-
Cost Effectiveness of Insulin Glargine versus Neutral Protamin Hagedorn Insulin in the Treatment of Type 2 Diabetes Patients in Turkey
por: Satman, Ilhan, et al.
Publicado: (2013) -
A comparison of intermediate and long-acting insulins in people with type 2 diabetes starting insulin: an observational database study
por: Gordon, J, et al.
Publicado: (2010) -
A Pragmatic Clinical Trial to Compare the Real-World Effectiveness of V-Go versus Standard Delivery of Insulin in Patients with Advanced Type 2 Diabetes
por: Cziraky, Mark J., et al.
Publicado: (2019) -
Cost-effectiveness of Simple Insulin Infusion Devices Compared to Multiple Daily Injections in Uncontrolled Type 2 Diabetics in the United States Based on a Simulation Model
por: Wahlqvist, Peter, et al.
Publicado: (2018) -
Insulin initiation in patients with type 2 diabetes mellitus:
treatment guidelines, clinical evidence and patterns of use of basal vs premixed
insulin analogues
por: Vaag, Allan, et al.
Publicado: (2012)